Trend analysis of the pulmonary tuberculosis registration in China from 2011 to 2015

doi:10.3969/j.issn.1000-6621.2018.06.005

Abstract

Abstract: Objective

To analyze the trend of the registration of active pulmonary tuberculosis (PTB) patients and new smear positive PTB patients in China (Excluding Hong Kong, Macao and Taiwan) from 2011 to 2015, and to provide reference for the evaluation of case detection and registration during the Twelfth Five-year TB Control Programme.

Methods

The numbers of active PTB and new smear positive PTB patients from 2011 to 2015 from the National Tuberculosis Information Management System were 4268687 and 1415537 respectively. The annual registration rates of active PTB and smear positive PTB patients, as well as the proportion of new smear positive PTB in active PTB were calculated and compared both nationwide and by provinces.

Results

In 2011 and 2015, the proportions of new smear positive PTB in active PTB were 41.6% (377005/905344) and 26.4% (210581/798927) respectively. The registration rates of active PTB and new smear positive PTB in 2011 were 67.5/100000 (905344/1340910000) and 28.1/100000 (377005/1340910000) respectively, while those in 2015 were 58.4/100000 (798927/1367820000) and 15.4/100000 (210581/1367820000) respectively. The registration rate of active PTB decreased by 1.2% from 2011 to 2012, 5.0% from 2012 to 2013, 3.4% from 2013 to 2014 and 2.6% from 2014 to 2015, so did that of new smear positive PTB (by 16.1% from 2011 to 2012, 12.8% from 2012 to 2013, 14.6% from 2013 to 2014 and 10.7% from 2014 to 2015). The proportion of new smear positive PTB in active PTB of 31 provinces ranged from 24.1% to 66.3% in 2011, from 20.7% to 63.1% in 2012, from 17.8% to 60.6% in 2013, from 13.8% to 49.6% in 2014 and from 12.3% to 48.1% in 2015.

Conclusion

There is a steady decline in the registration rate of active PTB but a significant decline in that of new smear positive PTB during the Twelfth Five-year TB Control Programme. Various measures need to be implemented to improve PTB case detection and registration.

Key words: Tuberculosis, pulmonary, Registries, Disease notification, Data interpretation, statistical, Comparative study

Dong-mei HU,Cai-hong XU,Xue LI,Xiao-qiu LIU. Trend analysis of the pulmonary tuberculosis registration in China from 2011 to 2015[J]. Chinese Journal of Antituberculosis, 2018, 40(6): 570-577. doi: 10.3969/j.issn.1000-6621.2018.06.005

Figures/Tables 4

省 (直辖市、自治区)	2011年			2012年			2013年			2014年			2015年
省 (直辖市、自治区)	新涂阳患者例数	活动性患者例数	比率 (%)	新涂阳患者例数	活动性患者例数	比率 (%)	新涂阳患者例数	活动性患者例数	比率 (%)	新涂阳患者例数	活动性患者例数	比率 (%)	新涂阳患者例数	活动性患者例数	比率 (%)
北京	1298	4520	28.7	1164	4315	27.0	1106	3856	28.7	1041	3840	27.1	1679	5838	28.8
天津	1080	3548	30.4	1023	3194	32.0	1144	3561	32.1	977	3219	30.4	985	3198	30.8
河北	17717	36913	48.0	15042	36285	41.5	12478	33409	37.3	8729	31931	27.3	7716	30686	25.1
山西	11367	23527	48.3	9204	21008	43.8	7732	18924	40.9	4573	15938	28.7	2836	15213	18.6
内蒙古	8163	18264	44.7	6067	17514	34.6	4280	14722	29.1	2663	11481	23.2	1990	10632	18.7
辽宁	9285	24696	37.6	8396	25335	33.1	7059	24528	28.8	5907	23225	25.4	5271	24804	21.3
吉林	8560	20791	41.2	6305	17592	35.8	4984	15821	31.5	4557	14811	30.8	3922	12970	30.2
黑龙江	12520	33119	37.8	9921	32705	30.3	9096	32911	27.6	8133	32856	24.8	6302	33108	19.0
上海	2495	7841	31.8	2333	7636	30.6	2309	7665	30.1	2204	7681	28.7	2081	7235	28.8
江苏	11418	38968	29.3	10127	38547	26.3	9038	35052	25.8	8484	33982	25.0	8369	31952	26.2
浙江	11501	35402	32.5	10210	34475	29.6	9849	31043	31.7	9616	31252	30.8	9252	29490	31.4
安徽	19413	35104	55.3	12698	35966	35.3	10777	34407	31.3	9836	33765	29.1	8651	32902	26.3
福建	9337	20027	46.6	8633	18768	46.0	8372	17765	47.1	7958	17469	45.6	7761	16602	46.7
江西	17730	37108	47.8	17102	35928	47.6	16545	33352	49.6	16820	33886	49.6	16150	33598	48.1
山东	16147	36910	43.7	12478	36584	34.1	10920	36330	30.1	8132	34898	23.3	7314	32534	22.5
河南	27804	67568	41.1	24216	69413	34.9	18822	64325	29.3	14374	63486	22.6	12475	60825	20.5
湖北	22841	46771	48.8	18455	47334	39.0	16143	44956	35.9	15088	43103	35.0	14066	41938	33.5
湖南	25624	56556	45.3	25627	58394	43.9	22772	57833	39.4	20842	56671	36.8	19779	55792	35.5
广东	34682	74272	46.7	33310	71852	46.4	31946	66331	48.2	26716	67379	39.7	20601	65502	31.5
广西	14544	39312	37.0	11158	38857	28.7	8445	37116	22.8	7557	35606	21.2	7180	34593	20.8
海南	3937	8567	46.0	2942	8561	34.4	2213	7450	29.7	1468	6968	21.1	1582	6849	23.1
重庆	9967	24402	40.8	7924	23740	33.4	6241	23098	27.0	4990	22048	22.6	4668	21346	21.9
四川	24174	63170	38.3	16188	60106	26.9	15980	57501	27.8	13590	53120	25.6	11749	50276	23.4
贵州	13038	43179	30.2	12300	42342	29.0	11752	41533	28.3	11233	39105	28.7	10381	40054	25.9
云南	12805	24421	52.4	8650	25990	33.3	6393	24574	26.0	5249	23778	22.1	4904	23884	20.5
西藏	866	3598	24.1	752	3625	20.7	690	3867	17.8	673	4126	16.3	517	3556	14.5
陕西	8483	23363	36.3	5707	22249	25.7	3939	21653	18.2	2757	19916	13.8	2395	19453	12.3
甘肃	8884	22491	39.5	6286	19854	31.7	5193	18354	28.3	3637	17420	20.9	2311	14466	16.0
青海	2414	3643	66.3	2255	3576	63.1	2173	3586	60.6	894	2607	34.3	842	2976	28.3
宁夏	1046	2924	35.8	668	2670	25.0	629	2468	25.5	696	2715	25.6	702	2598	27.0
新疆	7865	24369	32.3	9191	29784	30.9	6895	31646	21.8	6310	32298	19.5	6150	34057	18.1
合计	377005	905344	41.6	316332	894199	35.4	275915	849637	32.5	235704	820580	28.7	210581	798927	26.4

省 (直辖市、自治区)	2011年			2012年			2013年			2014年			2015年
省 (直辖市、自治区)	人口 (万)	活动性患者例数	登记率 (/10 万)	人口 (万)	活动性患者例数	登记率 (/10 万)	人口 (万)	活动性患者例数	登记率 (/10 万)	人口 (万)	活动性患者例数	登记率 (/10 万)	人口 (万)	活动性患者例数	登记率 (/10 万)
北京	1962	4520	23.0	2019	4315	21.4	2069	3856	18.6	2115	3840	18.2	2152	5838	27.1
天津	1299	3548	27.3	1355	3194	23.6	1413	3561	25.2	1472	3219	21.9	1517	3198	21.1
河北	7194	36913	51.3	7241	36285	50.1	7288	33409	45.8	7333	31931	43.5	7384	30686	41.6
山西	3574	23527	65.8	3593	21008	58.5	3611	18924	52.4	3630	15938	43.9	3648	15213	41.7
内蒙古	2472	18264	73.9	2482	17514	70.6	2490	14722	59.1	2498	11481	46.0	2505	10632	42.4
辽宁	4375	24696	56.4	4383	25335	57.8	4389	24528	55.9	4390	23225	52.9	4391	24804	56.5
吉林	2747	20791	75.7	2749	17592	64.0	2750	15821	57.5	2751	14811	53.8	2752	12970	47.1
黑龙江	3833	33119	86.4	3834	32705	85.3	3834	32911	85.8	3835	32856	85.7	3833	33108	86.4
上海	2303	7841	34.0	2347	7636	32.5	2380	7665	32.2	2415	7681	31.8	2426	7235	29.8
江苏	7869	38968	49.5	7899	38547	48.8	7920	35052	44.3	7939	33982	42.8	7960	31952	40.1
浙江	5447	35402	65.0	5463	34475	63.1	5477	31043	56.7	5498	31252	56.8	5508	29490	53.5
安徽	5957	35104	58.9	5968	35966	60.3	5988	34407	57.5	6030	33765	56.0	6083	32902	54.1
福建	3693	20027	54.2	3720	18768	50.5	3748	17765	47.4	3774	17469	46.3	3806	16602	43.6
江西	4462	37108	83.2	4488	35928	80.1	4504	33352	74.0	4522	33886	74.9	4542	33598	74.0
山东	9588	36910	38.5	9637	36584	38.0	9685	36330	37.5	9733	34898	35.9	9789	32534	33.2
河南	9405	67568	71.8	9388	69413	73.9	9406	64325	68.4	9413	63486	67.4	9436	60825	64.5
湖北	5728	46771	81.7	5758	47334	82.2	5779	44956	77.8	5799	43103	74.3	5816	41938	72.1
湖南	6570	56556	86.1	6596	58394	88.5	6639	57833	87.1	6691	56671	84.7	6737	55792	82.8
广东	10441	74272	71.1	10505	71852	68.4	10594	66331	62.6	10644	67379	63.3	10724	65502	61.1
广西	4610	39312	85.3	4645	38857	83.7	4682	37116	79.3	4719	35606	75.5	4754	34593	72.8
海南	869	8567	98.6	877	8561	97.6	887	7450	84.0	895	6968	77.9	903	6849	75.8
重庆	2885	24402	84.6	2919	23740	81.3	2945	23098	78.4	2970	22048	74.2	2991	21346	71.4
四川	8045	63170	78.5	8050	60106	74.7	8076	57501	71.2	8107	53120	65.5	8140	50276	61.8
贵州	3479	43179	124.1	3469	42342	122.1	3484	41533	119.2	3502	39105	111.7	3508	40054	114.2
云南	4602	24421	53.1	4631	25990	56.1	4659	24574	52.7	4687	23778	50.7	4714	23884	50.7
西藏	300	3598	119.9	303	3625	119.6	308	3867	125.6	312	4126	132.2	319	3556	111.5
陕西	3735	23363	62.6	3743	22249	59.4	3753	21653	57.7	3764	19916	52.9	3775	19453	51.5
甘肃	2560	22491	87.9	2564	19854	77.4	2578	18354	71.2	2582	17420	67.5	2591	14466	55.8
青海	563	3643	64.7	568	3576	63.0	573	3586	62.6	578	2607	45.1	583	2976	51.0
宁夏	633	2924	46.2	639	2670	41.8	647	2468	38.1	654	2715	41.5	662	2598	39.2
新疆	2891	24369	84.3	2902	29784	102.6	2848	31646	111.1	2820	32298	114.5	2833	34057	120.2
合计	134091	905344	67.5	134735	894199	66.4	135404	849637	62.7	136072	820580	60.3	136782	798927	58.4

省 (直辖市、自治区)	2011年			2012年			2013年			2014年			2015年
省 (直辖市、自治区)	人口 (万)	新涂阳患者例数	登记率 (/10 万)	人口 (万)	新涂阳患者例数	登记率 (/10 万)	人口 (万)	新涂阳患者例数	登记率 (/10 万)	人口 (万)	新涂阳患者例数	登记率 (/10 万)	人口 (万)	新涂阳患者例数	登记率 (/10 万)
北京	1962	1298	6.6	2019	1164	5.8	2069	1106	5.3	2115	1041	4.9	2152	1679	7.8
天津	1299	1080	8.3	1355	1023	7.5	1413	1144	8.1	1472	977	6.6	1517	985	6.5
河北	7194	17717	24.6	7241	15042	20.8	7288	12478	17.1	7333	8729	11.9	7384	7716	10.4
山西	3574	11367	31.8	3593	9204	25.6	3611	7732	21.4	3630	4573	12.6	3648	2836	7.8
内蒙古	2472	8163	33.0	2482	6067	24.4	2490	4280	17.2	2498	2663	10.7	2505	1990	7.9
辽宁	4375	9285	21.2	4383	8396	19.2	4389	7059	16.1	4390	5907	13.5	4391	5271	12.0
吉林	2747	8560	31.2	2749	6305	22.9	2750	4984	18.1	2751	4557	16.6	2752	3922	14.3
黑龙江	3833	12520	32.7	3834	9921	25.9	3834	9096	23.7	3835	8133	21.2	3833	6302	16.4
上海	2303	2495	10.8	2347	2333	9.9	2380	2309	9.7	2415	2204	9.1	2426	2081	8.6
江苏	7869	11418	14.5	7899	10127	12.8	7920	9038	11.4	7939	8484	10.7	7960	8369	10.5
浙江	5447	11501	21.1	5463	10210	18.7	5477	9849	18.0	5498	9616	17.5	5508	9252	16.8
安徽	5957	19413	32.6	5968	12698	21.3	5988	10777	18.0	6030	9836	16.3	6083	8651	14.2
福建	3693	9337	25.3	3720	8633	23.2	3748	8372	22.3	3774	7958	21.1	3806	7761	20.4
江西	4462	17730	39.7	4488	17102	38.1	4504	16545	36.7	4522	16820	37.2	4542	16150	35.6
山东	9588	16147	16.8	9637	12478	12.9	9685	10920	11.3	9733	8132	8.4	9789	7314	7.5
河南	9405	27804	29.6	9388	24216	25.8	9406	18822	20.0	9413	14374	15.3	9436	12475	13.2
湖北	5728	22841	39.9	5758	18455	32.1	5779	16143	27.9	5799	15088	26.0	5816	14066	24.2
湖南	6570	25624	39.0	6596	25627	38.9	6639	22772	34.3	6691	20842	31.1	6737	19779	29.4
广东	10441	34682	33.2	10505	33310	31.7	10594	31946	30.2	10644	26716	25.1	10724	20601	19.2
广西	4610	14544	31.5	4645	11158	24.0	4682	8445	18.0	4719	7557	16.0	4754	7180	15.1
海南	869	3937	45.3	877	2942	33.5	887	2213	24.9	895	1468	16.4	903	1582	17.5
重庆	2885	9967	34.5	2919	7924	27.1	2945	6241	21.2	2970	4990	16.8	2991	4668	15.6
四川	8045	24174	30.0	8050	16188	20.1	8076	15980	19.8	8107	13590	16.8	8140	11749	14.4
贵州	3479	13038	37.5	3469	12300	35.5	3484	11752	33.7	3502	11233	32.1	3508	10381	29.6
云南	4602	12805	27.8	4631	8650	18.7	4659	6393	13.7	4687	5249	11.2	4714	4904	10.4
西藏	300	866	28.9	303	752	24.8	308	690	22.4	312	673	21.6	319	517	16.2
陕西	3735	8483	22.7	3743	5707	15.2	3753	3939	10.5	3764	2757	7.3	3775	2395	6.3
甘肃	2560	8884	34.7	2564	6286	24.5	2578	5193	20.1	2582	3637	14.1	2591	2311	8.9
青海	563	2414	42.9	568	2255	39.7	573	2173	37.9	578	894	15.5	583	842	14.4
宁夏	633	1046	16.5	639	668	10.5	647	629	9.7	654	696	10.6	662	702	10.6
新疆	2891	7865	27.2	2902	9191	31.7	2848	6895	24.2	2820	6310	22.4	2833	6150	21.7
合计	134091	377005	28.1	134735	316332	23.5	135404	275915	20.4	136072	235704	17.3	136782	210581	15.4

References 14

[1]	中华人民共和国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. 国办发〔2017〕16号. 2017 -02-01.
[2]	中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011—2015年)的通知. 国办发〔2011〕53号.2011-11-17.
[3]	World Health Organization . Global tuberculosis control 2017. Geneva: World Health Organization, 2017.
[4]	中华人民共和国国家统计局. 中国统计年鉴(统计数据-年度数据)[DB/OL]. 北京:中华人民共和国国家统计局,2018( 2018- 03- 28)[2018-04-08]. .
[5]	中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版).北京: 中国协和医科大学出版社, 2009.
[6]	全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508.
[7]	中华人民共和国国家卫生和计划生育委员会. 中华人民共和国卫生行业标准-肺结核诊断(WS288-2017). 北京:中华人民共和国卫生部,2017(2017-11-09)[2018-04-09]. . 中华人民共和国卫生行业标准-肺结核诊断(WS288-2017). 北京:中华人民共和国卫生部,2017(2017-11-09)[2018-04-09]. .
[8]	马艳, 成诗明, 周林 , 等. 初治涂阴肺结核胸片复读结果与诊断质量多因素分析. 中国防痨杂志, 2011,33(11):707-712.
[9]	杜昕, 黄飞, 陆伟 , 等. 2010—2012年全国肺结核登记率变化趋势分析. 中国防痨杂志, 2013,35(5):337-342.
[10]	李俊, 刘小秋, 李雪 , 等. 中国全球基金项目结核病定点医院模式实施评价. 中国防痨杂志, 2013,35(10):778-782.
[11]	李涛, 成诗明, 杜昕 . 全国结核病防治工作模式与患者发现和治疗管理水平分析. 中国防痨杂志, 2015,37(1):30-33. doi: 10.3969/j.issn.1000-6621.2015.01.007 URL
[12]	虞浩, 陆伟, 周扬 , 等. 江苏省肺结核病人发现情况与转归队列分析. 江苏预防医学, 2011,2(6):6-8. doi: 10.3969/j.issn.1006-9070.2011.06.003 URL
[13]	谭慧敏, 张帆, 阳庆文 . 湖南省安仁县2001—2010年涂阳肺结核患者发现及治疗效果分析. 实用预防医学, 2011,18(11):2101-2103.
[14]	王黎霞, 李新旭, 张慧 , 等. 实施定点医院结核病防治模式影响因素调查. 中国热带医学, 2012,12(7):818-820.

[1]	Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
[2]	Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
[3]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[4]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[5]	Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[8]	Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
[9]	Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
[10]	Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
[11]	Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
[12]	Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
[13]	Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497.
[14]	Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
[15]	Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.